Volume 16, Issue 1 (5-2002)                   Med J Islam Repub Iran 2002 | Back to browse issues page

XML Print


From the Department of Immunology,Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, I.R. Iran. , immunol 2@sums.ac.ir
Abstract:   (4977 Views)
PSA is a 33-KDa serine protease that is produced predominantly by prostate epithelium. However, it has been shown that about 30-40% of female breast tumors produce PSA and its production is associated with the presence of estrogen and progesterone receptors. We have now developed a new tissue culture system to study PSA production in breast cancer and its association with prognostic factors such as progesterone receptor and c-erbB-2. For this purpose we investigated the ability of PSA production in five different cell lines, including two breast cancer cell lines, SK-Br-3 and MDA-MB-453. The PSA in tissue culture supernatant and cytoplasm of the Sk-Br-3 cell line was detected by western blotting and immunoperoxidase, respectively. Furthermore, we found lower expression of c-erbB-2 in Sk-Br-3 than non-PSA producer breast cancer cell line, MDA-MB- 453. Progesterone receptor was expressed by both PSA-positive and -negative cell lines and only the intensity of staining and the number of positive cells in SkBr- 3 population was higher than MDA-MB-453. According to our findings PSA can be considered as a good prognostic factor in breast cancer and we suggest that these two cell lines are a good in vitro model to study the relationship of different breast cancer prognostic factors and their regulations. Keywords: PSA, c-erbB-2, Progesterone receptor, Breast cancer, SK-Br-3.
Full-Text [PDF 648 kb]   (1780 Downloads)    

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.